These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16221756)

  • 1. Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma.
    Brightman FA; Leahy DE; Searle GE; Thomas S
    Drug Metab Dispos; 2006 Jan; 34(1):94-101. PubMed ID: 16221756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in rat plasma.
    Brightman FA; Leahy DE; Searle GE; Thomas S
    Drug Metab Dispos; 2006 Jan; 34(1):84-93. PubMed ID: 16221757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):603-11. PubMed ID: 15155551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models.
    Leahy DE
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):619-28. PubMed ID: 16859409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time.
    Ward KW; Smith BR
    Drug Metab Dispos; 2004 Jun; 32(6):612-9. PubMed ID: 15155552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
    Lüpfert C; Reichel A
    Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
    De Buck SS; Mackie CE
    Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies scaling and comparisons in drug development and toxicokinetics.
    Ings RM
    Xenobiotica; 1990 Nov; 20(11):1201-31. PubMed ID: 2275215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
    Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
    Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of human pharmacokinetics--evaluation of methods for prediction of volume of distribution.
    Fagerholm U
    J Pharm Pharmacol; 2007 Sep; 59(9):1181-90. PubMed ID: 17883888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.
    Obach RS; Baxter JG; Liston TE; Silber BM; Jones BC; MacIntyre F; Rance DJ; Wastall P
    J Pharmacol Exp Ther; 1997 Oct; 283(1):46-58. PubMed ID: 9336307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
    Evans CA; Jolivette LJ; Nagilla R; Ward KW
    Drug Metab Dispos; 2006 Jul; 34(7):1255-65. PubMed ID: 16621936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting total clearance in humans from chemical structure.
    Yu MJ
    J Chem Inf Model; 2010 Jul; 50(7):1284-95. PubMed ID: 20617831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting human pharmacokinetics from preclinical data.
    Poggesi I
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.